As many biotech and pharmaceutical organizations reorient their corporate identities to be more science-focused, it doesn’t hurt to have a moniker like Spectrum Science. According to CEO Jonathan ...
Spectrum Science is back with another strategic acquisition of a former MM+M Agency 100 honoree — this time in the world of clinical trial enrollment. The 2023 MM+M Agency 100 honoree announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results